Cancer Clinical Trial
Official title:
Colorectal Cancer Screening Intervention for Family Members of Colorectal Cancer Patients
This proposed study will use previous study results to guide the development and evaluation of interventions to improve CRC screening acceptance. The proposed study will evaluate the impact of three interventions to promote CRC screening among siblings in this increased-risk group, who are not currently compliant with CRC screening guidelines: 1) a generic print intervention; 2) a tailored print intervention, and; 3) a tailored print plus tailored telephone counseling intervention.
First-degree relatives of individuals with CRC are at increased-risk of developing
colorectal cancer (CRC). For these increased-risk individuals current guidelines recommend
initiating CRC screening a decade earlier than for those at average-risk for CRC; thus,
starting at age 40, or 10 years younger than the age at which the affected relative was
diagnosed with CRC. In our prior study of 504 at-risk siblings of patients with a history of
CRC, diagnosed at age less than 56, we found that approximately 44% of these siblings were
not compliant with CRC screening guidelines. Guided by the Transtheoretical, Health Belief
and Dual Process models, our prior study identified key attitudinal and non-attitudinal
predictors of screening behaviors and intentions.
This proposed study will use these results to guide the development and evaluation of
interventions to improve CRC screening acceptance. The proposed study will evaluate the
impact of three interventions to promote CRC screening among siblings in this increased-risk
group, who are not currently compliant with CRC screening guidelines: 1) a generic print
intervention; 2) a tailored print intervention, and; 3) a tailored print plus tailored
telephone counseling intervention.
Siblings in the generic print condition will receive a pamphlet about colorectal cancer
screening published by the Center for Disease Control. Siblings in the tailored print and
telephone counseling conditions will receive messages tailored specifically to their
responses on targeted attitudinal and non-attitudinal measures. Five hundred twenty four
siblings meeting eligibility criteria will be randomly assigned to one of the three
conditions after a baseline interview assessing CRC screening behaviors and attitudes, and
it is anticipated that 427 siblings will complete the study. For siblings in the tailored
conditions, baseline information will be utilized to design the tailored messages. After
receiving the intervention information, participants will be interviewed again six months
later regarding CRC screening behaviors and attitudes to assess the impact of the
intervention.
;
N/A
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|